Patents by Inventor Frank R. Prosl

Frank R. Prosl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210236698
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Application
    Filed: February 16, 2021
    Publication date: August 5, 2021
    Inventor: Frank R. Prosl
  • Publication number: 20200330651
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Application
    Filed: November 21, 2019
    Publication date: October 22, 2020
    Inventor: Frank R. Prosl
  • Publication number: 20190038813
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Application
    Filed: March 5, 2018
    Publication date: February 7, 2019
    Inventor: Frank R. Prosl
  • Publication number: 20170128629
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Application
    Filed: May 17, 2016
    Publication date: May 11, 2017
    Inventor: Frank R. Prosl
  • Patent number: 9339036
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising (A) at least one taurinamide derivative, and (B) heparin at a low concentration.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: May 17, 2016
    Assignee: ND Partners, LLC
    Inventor: Frank R. Prosl
  • Publication number: 20140243323
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Application
    Filed: September 24, 2013
    Publication date: August 28, 2014
    Applicant: ND Partners, LLC
    Inventor: Frank R. Prosl
  • Patent number: 8541393
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: September 24, 2013
    Assignee: ND Partners, LLC
    Inventor: Frank R. Prosl
  • Publication number: 20120208802
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Application
    Filed: September 2, 2011
    Publication date: August 16, 2012
    Inventor: Frank R. Prosl
  • Publication number: 20100331277
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Application
    Filed: March 12, 2010
    Publication date: December 30, 2010
    Inventor: Frank R. Prosl
  • Patent number: 7696182
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Grant
    Filed: November 2, 2004
    Date of Patent: April 13, 2010
    Assignee: ND Partners, LLC
    Inventor: Frank R. Prosl
  • Patent number: 7131962
    Abstract: A port device for implanting in a patient for subcutaneous access to the vascular system of the patient. The device includes a housing provided with apertures, each for receiving and retaining a needle. The housing is further provided with lock structure for locking catheters to the housing. The housing is configured internally to provide flow paths extending between needles disposed in the apertures and the catheters.
    Type: Grant
    Filed: March 9, 2000
    Date of Patent: November 7, 2006
    Assignee: ND Partners LLC
    Inventors: Brian K. Estabrook, Paul J. Smith, Harold M. Martins, Frank R. Prosl
  • Publication number: 20040230165
    Abstract: A member for mounting concentrically on a catheter and for disposition about a skin opening so as to be contiguous with the surfaces of the opening, the member being of sponge-like material, and an anti-microbial fluid disposed in the member and leachable onto the skin and into the opening.
    Type: Application
    Filed: October 14, 2003
    Publication date: November 18, 2004
    Inventors: Frank R. Prosl, Brian K. Estabrook, Paul J. Smith, Adrian C. Ravenscroft
  • Patent number: 6620118
    Abstract: Improved apparatus and method for the dialysis of blood. The improved apparatus comprises a subcutaneous port and catheter assembly comprising a connector portion comprising a subcutaneous port element, and a catheter portion comprising a catheter element. The improved apparatus also comprises a novel percutaneous catheter assembly comprising a catheter portion comprising a catheter element, and a connector portion comprising an extracorporeal connector element.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: September 16, 2003
    Assignee: Biolink Corporation
    Inventors: Frank R. Prosl, Brian K. Estabrook
  • Publication number: 20030167050
    Abstract: A member for mounting concentrically on a catheter and for disposition about a skin opening so as to be contiguous with the surfaces of the opening, the member being of sponge-like material, and an anti-microbial fluid disposed in the member and leachable onto the skin and into the opening.
    Type: Application
    Filed: January 19, 2001
    Publication date: September 4, 2003
    Inventors: Frank R. Prosl, Brian K. Estabrook, Paul J. Smith, Adrian C. Ravenscroft
  • Publication number: 20030163083
    Abstract: Improved apparatus for the dialysis of blood, a method for fabricating the same, and an improved method for the dialysis of blood.
    Type: Application
    Filed: September 10, 2002
    Publication date: August 28, 2003
    Applicant: Biolink Corporation
    Inventors: Brian K. Estabrook, Paul J. Smith, Frank R. Prosl, Harold M. Martins
  • Patent number: 6575945
    Abstract: An improvement in an implantable port of the type including a housing that is implanted within a subcutaneous tissue pocket is disclosed, wherein the improvement comprises the presence of metallic silver, an inorganic silver compound, a silver salt of an organic acid, or other antimicrobial substances such as taurolidine on the surfaces of the port in contact with, or proximate to, the tissue of said pocket.
    Type: Grant
    Filed: May 8, 2002
    Date of Patent: June 10, 2003
    Assignee: Biolink Corporation
    Inventors: Frank R. Prosl, Hans-Dietrich Polaschegg, Brian K. Estabrook, Klaus Sodemann
  • Publication number: 20030055374
    Abstract: Improved apparatus for the dialysis of blood, a method for fabricating the same, and an improved method for the dialysis of blood.
    Type: Application
    Filed: August 9, 2002
    Publication date: March 20, 2003
    Inventors: Harold M. Martins, Brian K. Estabrook, Frank R. Prosl, Paul J. Smith
  • Publication number: 20020177823
    Abstract: An improvement in an implantable port of the type including a housing that is implanted within a subcutaneous tissue pocket is disclosed, wherein the improvement comprises the presence of metallic silver, an inorganic silver compound, a silver salt of an organic acid, or other antimicrobial substances such as taurolidine on the surfaces of the port in contact with, or proximate to, the tissue of said pocket.
    Type: Application
    Filed: May 8, 2002
    Publication date: November 28, 2002
    Inventors: Frank R. Prosl, Hans-Dietrich Polaschegg, Brian K. Estabrook, Klaus Sodemann
  • Patent number: 6451003
    Abstract: An improvement in an implantable port of the type including a housing that is implanted within a subcutaneous tissue pocket is disclosed, wherein the improvement comprises the presence of metallic silver, an inorganic silver compound, a silver salt of an organic acid, or other antimicrobial substances such as taurolidine on the surfaces of the port in contact with, or proximate to, the tissue of said pocket.
    Type: Grant
    Filed: August 16, 2000
    Date of Patent: September 17, 2002
    Assignee: Biolink Corporation
    Inventors: Frank R. Prosl, Hans-Dietrich Polaschegg, Brian K. Estabrook, Klaus Sodemann
  • Patent number: 6447488
    Abstract: Improved apparatus for the dialysis of blood, a method for fabricating the same, and an improved method for the dialysis of blood.
    Type: Grant
    Filed: March 19, 1998
    Date of Patent: September 10, 2002
    Assignee: Biolink Corporation
    Inventors: Brian K. Estabrook, Paul J. Smith, Frank R. Prosl, Harold M. Martins